Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapy

• Yazar: Sarah eCrawford (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Frontiers Media S.A., 2013-06-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

U.S. SEER data for age-adjusted mortality rates for all cancers combined for all races show only a modest overall 13% decline over the past 35 years. Moreover, the greatest contributor to cancer mortality is treatment resistant metastatic disease. The accepted therapeutic paradigm for the past half...